A Prospective, Non-controlled, Clinical Investigation of the Vanguard™ Complete Knee System
A Prospective, Non-controlled, Clinical Investigation of the Vanguard™ Complete Knee System
The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.
This is a 10-year prospective observational data collection on the Vanguard Total Knee system. Patients are asked to come in for a preop, operative, immediate post-operative, 6 Month, 1 Year, 3 Year,5 Year, 7 year, and 10 year visits to check on the function, range of motion, and radiographic assessment of their total knee device.
The Vanguard Knee is an FDA cleared device, and has been on the market since 2004.
Inclusion criteria:
Patient selection factors to be considered include:
Exclusion criteria:
Absolute contraindications include:
Relative contraindications include:
Additional exclusion criteria includes: failure of a previous joint replacement